Revive Therapeutics, Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Vaughan ON Canada (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2015
NCT02330796
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Revive Therapeutics, Ltd.